NCT00689442 - Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels | Biotech Hunter

Enrollment

105

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

March 31, 2006

Conditions

Dyslipidemia

Interventions

DRUG

JTT-705 600 mg and atorvastatin 20 mg

"* JTT-705 300 mg tablets, 600 mg dose, oral, once daily, immediately following breakfast and/or assessment~* Atorvastatin 20 mg tablets, 20 mg dose, oral, once daily, immediately following breakfast and/or assessments"

DRUG

Placebo and atorvastatin 20 mg

"* Placebo tablet, 2 tablets, oral, once daily, immediately following breakfast and/or assessments~* Atorvastatin 20 mg tablets, one tablet, oral, once daily, immediately following breakfast and/or assessments"

Trial Locations (1)

Unknown

Amsterdam